Agilon Health Inc [AGL] stock prices are up 2.63% to $1.17 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The AGL shares have gain 8.33% over the last week, with a monthly amount drifted -6.40%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Agilon Health Inc [NYSE: AGL] stock has seen the most recent analyst activity on August 20, 2025, when Bernstein downgraded its rating to a Mkt Perform but kept the price target unchanged to $1.40 for it. Previously, Citigroup downgraded its rating to Neutral on August 06, 2025, and kept the price target unchanged to $1. On April 25, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $5 on the stock. Bernstein upgraded its rating to a Outperform but stick to its price target of $8.50 on April 08, 2025. Citigroup upgraded its rating to a Neutral and raised its price target to $2.25 on January 10, 2025. In a note dated December 16, 2024, Macquarie initiated an Neutral rating.
The stock price of Agilon Health Inc [AGL] has been fluctuating between $0.71 and $6.08 over the past year. Currently, Wall Street analysts expect the stock to reach $1.1 within the next 12 months. Agilon Health Inc [NYSE: AGL] shares were valued at $1.17 at the most recent close of the market. An investor can expect a potential drop of -5.98% based on the average AGL price forecast.
Analyzing the AGL fundamentals
The Agilon Health Inc [NYSE:AGL] reported sales of 5.90B for trailing twelve months, representing a drop of -5.92%. Gross Profit Margin for this corporation currently stands at -0.02% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.18, Equity is -0.65 and Total Capital is -0.82. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Agilon Health Inc [NYSE:AGL]’s Current Ratio is 1.16. In addition, the Quick Ratio stands at 1.16 and the Cash Ratio stands at 0.14. Considering the valuation of this stock, the price to sales ratio is 0.08, the price to book ratio is 1.19.
Transactions by insiders
Recent insider trading involved McLoughlin Karen, Director, that happened on Dec 13 ’24 when 25000.0 shares were purchased. Director, Battaglia Silvana completed a deal on Dec 11 ’24 to buy 25062.0 shares. Meanwhile, Director MCKENZIE DIANA bought 12500.0 shares on Nov 25 ’24.
